Suscribirse

Whole-lesion iodine map histogram analysis versus single-slice spectral CT parameters for determining novel International Association for the Study of Lung Cancer grade of invasive non-mucinous pulmonary adenocarcinomas - 02/05/24

Doi : 10.1016/j.diii.2023.12.001 
Liangna Deng a, b, c, d, 1, Jingjing Yang a, b, c, d, 1, Mingtao Zhang c, e, 1, Kaibo Zhu a, b, c, d, Mengyuan Jing a, b, c, d, Yuting Zhang a, b, c, d, Bin Zhang a, b, c, d, Tao Han a, b, c, d, Junlin Zhou a, b, c, d,
a Department of Radiology, Lanzhou University Second Hospital, Lanzhou 730000, China 
b Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou 730000, China 
c Second Clinical School, Lanzhou University, Lanzhou 730000, China 
d Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou 730000, China 
e Department of Orthopedics, Lanzhou University Second Hospital, 730000, China 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

The whole-lesion iodine map histogram analysis and single-slice spectral computed tomography parameters can predict the novel International Association for the Study of Lung Cancer grade of invasive non-mucinous pulmonary adenocarcinoma.
Among histogram parameters, the first percentile has the highest diagnostic performance to predict the novel International Association for the Study of Lung Cancer grade of invasive non-mucinous pulmonary adenocarcinoma, while among spectral parameters, iodine concentration has the highest diagnostic performance.
Whole-lesion iodine map histogram analysis and single-slice spectral computed tomography parameters present not different diagnostic performances for determining the novel International Association for the Study of Lung Cancer grade of invasive non-mucinous pulmonary adenocarcinoma.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to evaluate and compare the performances of whole-lesion iodine map histogram analysis to those of single-slice spectral computed tomography (CT) parameters in discriminating between low-to-moderate grade invasive non-mucinous pulmonary adenocarcinoma (INMA) and high-grade INMA according to the novel International Association for the Study of Lung Cancer grading system of INMA.

Materials and methods

Sixty-one patients with INMA (34 with low-to-moderate grade [i.e., grade I and grade II] and 27 with high grade [i.e., grade III]) were evaluated with spectral CT. There were 28 men and 33 women, with a mean age of 56.4 ± 10.5 (standard deviation) years (range: 29–78 years). The whole-lesion iodine map histogram parameters (mean, standard deviation, variance, skewness, kurtosis, entropy, and 1st, 10th, 25th, 50th, 75th, 90th, and 99th percentile) were measured for each INMA. In other sessions, by placing regions of interest at representative levels of the tumor and normalizing them, spectral CT parameters (iodine concentration and normalized iodine concentration) were obtained. Discriminating capabilities of spectral CT and histogram parameters were assessed and compared using area under the ROC curve (AUC) and logistic regression models.

Results

The 1st, 10th, and 25th percentiles of the iodine map histogram analysis, and iodine concentration and normalized iodine concentration of single-slice spectral CT parameters were significantly different between high-grade and low-to-moderate grade INMAs (P < 0.001 to P = 0.002). The 1st percentile of histogram parameters (AUC, 0.84; 95% confidence interval [CI]: 0.73–0.92) and iodine concentration (AUC, 0.78; 95% CI: 0.66–0.88) from single-slice spectral CT parameters had the best performance for discriminating between high-grade and low-to-moderate grade INMAs. At ROC curve analysis no significant differences in AUC were found between histogram parameters (AUC = 0.86; 95% CI: 0.74–0.93) and spectral CT parameters (AUC = 0.81; 95% CI: 0.74–0.93) (P = 0.60).

Conclusion

Both whole-lesion iodine map histogram analysis and single-slice spectral CT parameters help discriminate between low-to-moderate grade and high-grade INMAs according to the novel International Association for the Study of Lung Cancer grading system, with no differences in diagnostic performances.

El texto completo de este artículo está disponible en PDF.

Keywords : Biomarkers, iodine map, Lung adenocarcinoma, Spectral CT, Tumor grading

Abbreviations : AUC, CT, IASLC, IC, ICC, INMA, NIC, ROI, SD


Esquema


© 2023  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 105 - N° 5

P. 165-173 - mai 2024 Regresar al número
Artículo precedente Artículo precedente
  • Pulmonary fibrosis is uncommon in primary Sjögren disease
  • Salim Aymeric Si-Mohamed, Vincent Cottin
| Artículo siguiente Artículo siguiente
  • Abdominal aortic calcium and geometry in patients with essential hypertension
  • Damian Craiem, Federico Guilenea, Jean-Batiste de Freminville, Michel Azizi, Mariano E. Casciaro, Umit Gencer, Anne-Sophie Jannot, Laurence Amar, Gilles Soulat, Elie Mousseaux

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.